MISSION
To serve as the definitive resource for human simulation technologiesâorganoids, organ-on-chip, digital twins, and AI drug discoveryâsupporting the transition away from animal testing toward more predictive, human-relevant models.
WHAT WE PROVIDE
RESEARCH
Scientific Documentation
Comprehensive coverage of peer-reviewed research, clinical data, and regulatory developments from 1,076+ authoritative sources.
MARKET
Industry Intelligence
Market analysis, company profiles, funding trends, and partnership announcements across the human simulation sector.
REGULATORY
Policy Tracking
Coverage of FDA Modernization Act, NCATS programs, EMA initiatives, and global regulatory developments.
PORTFOLIO
Strategic Domains
85+ premium domains aligned with industry terminology and regulatory frameworks for institutional acquisition.